Outeiro, Tiago Fleming

Home >> Publications >> Author >> Outeiro, Tiago Fleming >> Page 8
Feature image not available
01.03.2021

Doxycycline interferes with tau amyloid aggregation abolishing its associated neuronal toxicity

Authors Medina L, González-Lizárraga F, Dominguez-Meijide A, Ploper D, Parrales V, Sequeira S, Cima-Omori MS, Zweckstetter M, Del Bel E, Michel PP, Outeiro TF, Raisman-Vozari R, Chehín R, Socias SB Journal Frontiers in Aging Neuroscience Citation Front Aging Neurosci. 2021 Mar 22;13:635760. Abstract Tauopathies are neurodegenerative disorders with increasing incidence
Learn More
Feature image not available
24.02.2021

Emerging concepts in synucleinopathies

Authors Outeiro TF Journal Acta Neuropathologica (Editorial) Citation Acta Neuropathol. 2021 Feb 24. Abstract No abstract available DOI 10.1007/s00401-021-02290-7 Pubmed Link  
Learn More
Feature image not available
12.02.2021

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies

Authors Brás IC, Outeiro TF Journal Cells Citation Cells 2021, 10(2), 375. Abstract The accumulation of misfolded alpha-synuclein (aSyn) throughout the brain, as Lewy pathology, is a phenomenon central to Parkinson’s disease (PD) pathogenesis. The stereotypical distribution and evolution of the pathology during disease is often attributed to the cell-to-cell
Learn More
Feature image not available
30.01.2021

Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

Authors Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I Journal Acta Neuropathologica Citation Acta Neuropathol. 2021 Jan 30. Abstract Accumulation of the protein α-synuclein into insoluble intracellular deposits termed Lewy bodies (LBs) is the characteristic neuropathological feature of LB diseases, such as Parkinson’s disease (PD), Parkinson’s
Learn More
Feature image not available
08.01.2021

Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

Authors Dominguez-Meijide A, Parrales V, Vasili E, González-Lizárraga F, König A, Lázaro DF, Lannuzel A, Haik S, Del Bel E, Chehín R, Raisman-Vozari R, Michel PP, Bizat N, Outeiro TF Journal Neurobiology of Disease Citation Neurobiol Dis. 2021 Jan 8;151:105256. Abstract Parkinson’s disease (PD) and dementia with Lewy bodies (DLB)
Learn More
Feature image not available
07.01.2021

Alpha-Synuclein Antibody Characterization: Why Semantics Matters

Authors Outeiro TF Journal Molecular Neurobiology Citation Mol Neurobiol. 2021 Jan 7. Abstract In protein aggregation disorders, we assume that, during the process of protein aggregation, different types of aggregated species (oligomers, protofibrils, fibrils, etc.) are formed, some of which can be toxic to cells/tissues/organs. Recent evidence from numerous studies
Learn More
Feature image not available
01.01.2021

JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson’s disease: Mitochondrial protection and antioxidant properties

Authors Fonseca-Fonseca LA, da Silva VDA, Wong-Guerra M, Ramírez-Sánchez J, Yaquis ASP, Ochoa-Rodríguez E, Verdecia-Reyes Y, de Araújo FM, Santana RC, Outeiro TF, Costa SL, Núñez-Figueredo Y Journal Neurotoxicology Citation Neurotoxicology. 2021 Jan;82:89-98. Abstract We have previously shown that JM-20, a new chemical entity consisting of 1,5-benzodiazepine fused to a
Learn More
Feature image not available
21.12.2020

Cancer and Parkinson’s Disease: Common Targets, Emerging Hopes

Authors Filippou PS, Outeiro TF Journal Movement Disorders Citation Mov Disord. 2020 Dec 21. Abstract Cancer and neurodegeneration are two major leading causes of morbidity and death worldwide. At first sight, the two fields do not seem to share much in common and, if anything, might be placed on opposite
Learn More
Feature image not available
09.12.2020

Alpha-synuclein oligomerization and aggregation: a model will always be a model

Authors Outeiro TF Journal Journal of Neurochemistry Citation J Neurochem. 2020 Dec 9. Abstract Many different types of protein aggregates have attracted the minds and curiosity of countless armies of scientists, i.e., laboratories, in the world for more than 100 years. For example, it was in 1912 that F. Lewy
Learn More
Feature image not available
16.11.2020

From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson’s Disease

Authors Outeiro TF, Heutink P, Bezard E, Cenci AM Journal Movement Disorders Citation Mov Disord. 2020 Nov 16. Abstract Parkinson’s disease (PD) is primarily known as a movement disorder because of typical clinical manifestations associated with the loss of dopaminergic neurons in the substantia nigra. However, it is now widely
Learn More
X

Open Positions

EN DE
X
X